NOVA Versugen
R1 300,00
-
Blood vessel support
-
Cardiovascular wellness
-
Anti-aging
-
Recovery support
Guarantee safe & secure checkout
Description
-
Blood vessel support
-
Cardiovascular wellness
-
Anti-aging
-
Recovery support
Additional information
| Colour | Emerald Green, Royal Blue, Burnt Orange, Turquoise Teal, Mustard Yellow |
|---|
Quick Comparison
| NOVA Versugen remove | NOVA Mito Boost remove | BP BPC157 & TB500 remove | NOVA Fat Away remove | HDL Tirze 30 remove | HDL Semag 10 remove | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | NOVA Versugen remove | NOVA Mito Boost remove | BP BPC157 & TB500 remove | NOVA Fat Away remove | HDL Tirze 30 remove | HDL Semag 10 remove | ||||||||||||
| Image | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ||||||||||||
| SKU | IN_LK-28 | IN_LK-23 | IN_LK | IN_LK-18 | IN_LK-13 | IN_LK-11 | ||||||||||||
| Rating | ||||||||||||||||||
| Price | R1 300,00 | R1 050,00 | R2 200,00 | R1 300,00 | R2 100,00 | R1 450,00 | ||||||||||||
| Stock | ||||||||||||||||||
| Weight | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||
| Additional information |
|
|
|
|
|
| ||||||||||||
| Description |
| Mito Boost is a high-potency MOTS-c peptide pen designed to optimise mitochondrial function. It works at a cellular level to enhance energy production, endurance, recovery, and overall longevity. | This blend combines two well-studied regenerative peptides: BPC-157 (Body Protection Compound-157), a pentadecapeptide derived from human gastric juice with cytoprotective and wound-healing properties[1][2], and TB-500 (Thymosin Beta-4 fragment), a 43-amino-acid peptide involved in tissue repair, cell migration, and angiogenesis[3][4]. | Supports fat metabolism and body composition by targeting stubborn fat while preserving lean muscle. | Experience the dual-action power of Tirzepatide 30mg from The Clinic, a next-generation injectable peptide designed to target two key hormone pathways: GLP-1 and GIP. | Semaglutide activates the GLP-1 (glucagon-like peptide-1) receptor, producing multiple downstream effects: enhanced insulin secretion in response to meals, suppressed glucagon output, delayed gastric emptying, and reduced appetite signals. | ||||||||||||
| Add to cart |

Reviews
There are no reviews yet.